• Blundell N, Taylor-Phillips S, Spitzer D, Martin S, Forde I, Clarke A. Elective surgical referral guidelines--background educational material or essential shared decision making tool? A survey of GPs' in England. BMC family practice. 2011;12:92.
• Clarke A, Friede T, Putz R, Ashdown J, Martin S, Blake A, Adi Y, Parkinson J, Flynn P, Platt S, Stewart-Brown S. Warwick-Edinburgh Mental Well-being Scale (WEMWBS): validated for teenage school students in England and Scotland. A mixed methods assessment. BMC Public Health. 2011;11:487.
• Connock M, Hyde C, Moore D. Cautions regarding the fitting and interpretation of survival curves: examples from NICE single technology appraisals of drugs for cancer. PharmacoEconomics. 2011;29(10):827-37.
• Connock M CE, Shyangdan D, Hall B, Grove A, Clarke A. Abiraterone acetate for the treatment of metastatic, castrate-resistant prostate cancer following previous cytotoxic chemotherapy: A Single Technology Appraisal. 2011.
• Gkeredakis E, Swan J, Powell J, Nicolini D, Scarbrough H, Roginski C, Taylor-Phillips S, Clarke A. Mind the gap: Understanding utilisation of evidence and policy in health care management practice. Journal of health organization and management. 2011;25(3):298-314.
• Hind D, Wailoo AJ, Sutcliffe P. Demands for 'off-licence' access to trastuzumab (Herceptin): content analysis of UK newspaper articles. Health expectations : an international journal of public participation in health care and health policy. 2011;14(1):38-47.
• Kandala NB, Brodish P, Buckner B, Foster S, Madise N. Millennium development goal 6 and HIV infection in Zambia: what can we learn from successive household surveys? AIDS (London, England). 2011;25(1):95-106.
• Kandala N-B, Madungu TP, Emina JB, Nzita KP, Cappuccio FP. Malnutrition among children under the age of five in the Democratic Republic of Congo (DRC): does geographic location matter? BMC Public Health. 2011;11(1):1-15.
• Karmaker B, Kandala NB, Chung D, Clarke A. Factors associated with female genital mutilation in Burkina Faso and its policy implications. International journal for equity in health. 2011;10:20.
• Khatab K, Felten M, Kandala N-B, Ghilagaber G, Kraus T. Risk factors associated with asbestos-related lung diseases among different sub-cohorts of formerly asbestos exposed workers in Germany. Occupational and Environmental Medicine. 2011;68(Suppl 1):A71-A.
• Maclennan SJ, Maclennan SJ, Imamura M, Omar MI, Vale L, Lam T, Royle P, Royle J, Swami S, Pickard R, McClinton S, Griffiths TR, Dahm P, N'Dow J. Urological cancer care pathways: development and use in the context of systematic reviews and clinical practice guidelines. World journal of urology. 2011;29(3):291-301.
• Martin S, Sutcliffe P, Griffiths F, Sturt J, Powell J, Adams A, Dale J. Effectiveness and impact of networked communication interventions in young people with mental health conditions: a systematic review. Patient education and counseling. 2011;85(2):e108-19.
• McKee M, Pollock AM, Clarke A, McCoy D, Middleton J, Raine R, Scott-Samuel A. In defence of the NHS: why writing to the House of Lords was necessary. BMJ (Clinical research ed). 2011;343:d6535.
• Meredith JO, Grove AL, Walley P, Young F, Macintyre MB. Are we operating effectively? A lean analysis of operating theatre changeovers. Operations Management Research. 2011;4(3):89-98.
• Murthy BN, Kandala N-B, Ezhil R, Kaur P, Sudha R. Statistical issues in studying the relative importance of body mass index, waist circumference, waist hip ratio and waist stature ratio to predict type 2 diabetes. Journal of Applied Statistics. 2011;38(9):2063-70.
• Musila N, Underwood M, McCaskie AW, Black N, Clarke A, van der Meulen JH. Referral recommendations for osteoarthritis of the knee incorporating patients' preferences. Family practice. 2011;28(1):68-74.
• Royle P CE, Walker C, Chong S, Kandala N-B, Waugh N. Botulinum toxin type A for the prophylaxis of headaches in adults with chronic migraine: a single technology appraisal. 2011.
• Royle P CE, Henderson R, Lois N, Shyangdan D, Waugh N. Ranibizumab for the treatment of diabetic macular oedema: a single technology appraisal. 2011.
• Scotland G, Waugh N, Royle P, McNamee P, Henderson R, Hollick R. Denosumab for the prevention of osteoporotic fractures in post-menopausal women: a NICE single technology appraisal. PharmacoEconomics. 2011;29(11):951-61.
• Shyangdan D, Clar C, Ghouri N, Henderson R, Gurung T, Preiss D, Sattar N, Fraser A, Waugh N. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. Health technology assessment (Winchester, England). 2011;15(38):1-110.
• Shyangdan D, Cummins E, Royle P, Waugh N. Liraglutide for the treatment of type 2 diabetes. Health technology assessment (Winchester, England). 2011;15 Suppl 1:77-86.
• Shyangdan DS, Royle P, Clar C, Sharma P, Waugh N, Snaith A. Glucagon-like peptide analogues for type 2 diabetes mellitus. The Cochrane database of systematic reviews. 2011(10):Cd006423.
• Sutcliffe P, Martin S, Sturt J, Powell J, Griffiths F, Adams A, Dale J. Systematic review of communication technologies to promote access and engagement of young people with diabetes into healthcare. BMC endocrine disorders. 2011;11:1.
• Waugh N MA, Robertson L, Royle P. Research review for the Scottish Public Health Network. Screening for and prevention of type 2 diabetes. 2011.

You do not have permission to access the remote content.